Immunodeficiency Therapeutics Market, by Therapy Type (Immunoglobulin Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy, and Others), by Test Type (Blood Test and Prenatal Testing), by Disease Type (Antibody Deficiency, Cellular Immunodeficiency, I
Description
Immunodeficiency Therapeutics Market, by Therapy Type (Immunoglobulin Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy, and Others), by Test Type (Blood Test and Prenatal Testing), by Disease Type (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Immunodeficiency disorders or diseases render the ability of the immune system to fight against microbial infection, thus making a person immuno-compromised. Thus, people suffering from immunodeficiency diseases or disorders are more likely to fall sick. An immunodeficiency disorder may be either congenital or acquired. Congenital immunodeficiency disorder refers to the one which occurs by birth while acquired disorder refers to the one which occurs later in life. For instance, primary immunodeficiency disease is a congenital immunodeficiency disease which is a result of defect in genes that regulate the immune system. These genes are involved in functioning of immune organs such as spleen, lymph nodes, bone marrow, tonsils, and others. Some of the common primary immunodeficiency diseases include X-linked agammaglobulinemia (XLA), common variable, immunodeficiency (CVID), and severe combined immunodeficiency (SCID). Human immunodeficiency virus, spleen removal surgery, unsanitary conditions, and malnutrition are the most common causes of immunodeficiency disorders. Immunodeficiency diseases or disorders may exhibit signs such as yeast infection, cold, pink eye, diarrhea, pneumonia, and others. Recent advances in the field of immunology and genetics has created large number of opportunities for development and commercialization of newer, safer, and more efficient immunodeficiency therapeutics.
Market Dynamics
Market players are conducting clinical trials for developing safer and more efficient treatments for immunodeficiency diseases, which could contribute to the growth of the global immunodeficiency therapeutics market over the forecast period. For instance, in March 2017, Octapharma AG, a Switzerland based pharmaceutical company initiated phase III clinical trial study to investigate the efficiency, safety and tolerability of its product Octanorm (cutaquig) which is a ready to use liquid formulation of normal human IgG to be administered subcutaneously for treatment of primary immunodeficiency disease. The results for this clinical study were published by PubMed in April 2021, and show that Octanorm, manufactured by Octapharma AG is safe for indicated use.
Market players are focusing on launch of products, which is expected to strengthen their position in the global immunodeficiency therapeutics market. For instance, in June 2019, Octapharma AG launched its new product called cutaquig which is a 16.5% immune globulin solution to be used for treatment of primary humoral immunodeficiency.
Market players are involved in inorganic business strategies such a partnership to strengthen their position globally, this is expected to drive the growth of the global immunodeficiency therapeutics market. For instance, in January 2021, SAB Biotherapeutics Inc., a U.S. based biotechnology company entered into a collaborative partnership with CSL Behring, a U.S. based biopharmaceutical company to carry out research based on novel therapies which could be used for treatment of immune disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), primary immunodeficiency disease, and others.
Key features of the study:
This report provides an in-depth analysis of global immunodeficiency therapeutics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global immunodeficiency therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Pfizer Inc., CSL Behring, Grifols, S.A., Abbott, ADMA Biologics, Inc., AstraZeneca, Baxter, Bayer AG, Biocon, Bristol-Myers Squibb Company, BDI Pharma, Inc., Bharat Serums and Vaccines Ltd., Eli Lilly and Company, GlaxoSmithKline plc., Lupin Pharmaceuticals Inc., Novartis AG, Octapharma AG, Sanofi, and Takeda Pharmaceutical Company Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global immunodeficiency therapeutics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global immunodeficiency therapeutics market
Detailed Segmentation:
Global Immunodeficiency Therapeutics Market, By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
Global Immunodeficiency Therapeutics Market, By Test Type:
Blood Test
Prenatal Testing
Global Immunodeficiency Therapeutics Market, By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
Global Immunodeficiency Therapeutics Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Immunodeficiency Therapeutics Market, By Region:
North America
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
U.S.
Canada
Latin America
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Pfizer Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
CSL Behring
Grifols, S.A.
Abbott
ADMA Biologics, Inc.
AstraZeneca
Baxter
Bayer AG
Biocon
Bristol-Myers Squibb Company
BDI Pharma, Inc.
Bharat Serums and Vaccines Ltd.
Eli Lilly and Company
GlaxoSmithKline plc.
Lupin Pharmaceuticals Inc.
Novartis AG
Octapharma AG
Sanofi
Takeda Pharmaceutical Company Limited
“*” marked represents similar segmentation in other categories in the respective section.
Immunodeficiency disorders or diseases render the ability of the immune system to fight against microbial infection, thus making a person immuno-compromised. Thus, people suffering from immunodeficiency diseases or disorders are more likely to fall sick. An immunodeficiency disorder may be either congenital or acquired. Congenital immunodeficiency disorder refers to the one which occurs by birth while acquired disorder refers to the one which occurs later in life. For instance, primary immunodeficiency disease is a congenital immunodeficiency disease which is a result of defect in genes that regulate the immune system. These genes are involved in functioning of immune organs such as spleen, lymph nodes, bone marrow, tonsils, and others. Some of the common primary immunodeficiency diseases include X-linked agammaglobulinemia (XLA), common variable, immunodeficiency (CVID), and severe combined immunodeficiency (SCID). Human immunodeficiency virus, spleen removal surgery, unsanitary conditions, and malnutrition are the most common causes of immunodeficiency disorders. Immunodeficiency diseases or disorders may exhibit signs such as yeast infection, cold, pink eye, diarrhea, pneumonia, and others. Recent advances in the field of immunology and genetics has created large number of opportunities for development and commercialization of newer, safer, and more efficient immunodeficiency therapeutics.
Market Dynamics
Market players are conducting clinical trials for developing safer and more efficient treatments for immunodeficiency diseases, which could contribute to the growth of the global immunodeficiency therapeutics market over the forecast period. For instance, in March 2017, Octapharma AG, a Switzerland based pharmaceutical company initiated phase III clinical trial study to investigate the efficiency, safety and tolerability of its product Octanorm (cutaquig) which is a ready to use liquid formulation of normal human IgG to be administered subcutaneously for treatment of primary immunodeficiency disease. The results for this clinical study were published by PubMed in April 2021, and show that Octanorm, manufactured by Octapharma AG is safe for indicated use.
Market players are focusing on launch of products, which is expected to strengthen their position in the global immunodeficiency therapeutics market. For instance, in June 2019, Octapharma AG launched its new product called cutaquig which is a 16.5% immune globulin solution to be used for treatment of primary humoral immunodeficiency.
Market players are involved in inorganic business strategies such a partnership to strengthen their position globally, this is expected to drive the growth of the global immunodeficiency therapeutics market. For instance, in January 2021, SAB Biotherapeutics Inc., a U.S. based biotechnology company entered into a collaborative partnership with CSL Behring, a U.S. based biopharmaceutical company to carry out research based on novel therapies which could be used for treatment of immune disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), primary immunodeficiency disease, and others.
Key features of the study:
This report provides an in-depth analysis of global immunodeficiency therapeutics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global immunodeficiency therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Pfizer Inc., CSL Behring, Grifols, S.A., Abbott, ADMA Biologics, Inc., AstraZeneca, Baxter, Bayer AG, Biocon, Bristol-Myers Squibb Company, BDI Pharma, Inc., Bharat Serums and Vaccines Ltd., Eli Lilly and Company, GlaxoSmithKline plc., Lupin Pharmaceuticals Inc., Novartis AG, Octapharma AG, Sanofi, and Takeda Pharmaceutical Company Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global immunodeficiency therapeutics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global immunodeficiency therapeutics market
Detailed Segmentation:
Global Immunodeficiency Therapeutics Market, By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
Global Immunodeficiency Therapeutics Market, By Test Type:
Blood Test
Prenatal Testing
Global Immunodeficiency Therapeutics Market, By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
Global Immunodeficiency Therapeutics Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Immunodeficiency Therapeutics Market, By Region:
North America
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
U.S.
Canada
Latin America
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapy Type:
Immunoglobulin Therapy
Antibiotics Therapy
Stem Cell and Gene Therapy
Others
By Test Type:
Blood Test
Prenatal Testing
By Disease Type:
Antibody Deficiency
Cellular Immunodeficiency
Innate Immune Disorders
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Pfizer Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
CSL Behring
Grifols, S.A.
Abbott
ADMA Biologics, Inc.
AstraZeneca
Baxter
Bayer AG
Biocon
Bristol-Myers Squibb Company
BDI Pharma, Inc.
Bharat Serums and Vaccines Ltd.
Eli Lilly and Company
GlaxoSmithKline plc.
Lupin Pharmaceuticals Inc.
Novartis AG
Octapharma AG
Sanofi
Takeda Pharmaceutical Company Limited
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
163 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Distribution Chanel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Industry Trends
- Pipeline Analysis
- Key Highlights
- Epidemiology
- Pricing List
- Regulatory Scenario
- Global Supply Chain Analysis
- 4. COVID – 19 Impact Analysis
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Immunodeficiency Therapeutics
- Impact of Covid-19 on the Immunodeficiency Therapeutics Market
- 5. Global Immunodeficiency Therapeutics Market, By Therapy Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Immunoglobulin Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Antibiotics Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Stem Cell and Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 6. Global Immunodeficiency Therapeutics Market, By Test Type, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Blood Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 7. Global Immunodeficiency Therapeutics Market, By Disease Type, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Antibody Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cellular Immunodeficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Innate Immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 8. Global Immunodeficiency Therapeutics Market, By Distribution Channel, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 9. Global Immunodeficiency Therapeutics Market, By Region, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 10. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- CSL Behring
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Grifols, S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Abbott
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- ADMA Biologics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- AstraZeneca
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Baxter
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Biocon
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bristol-Myers Squibb Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- BDI Pharma, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bharat Serums and Vaccines Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Lupin Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Octapharma AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Analyst Views
- 11. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 35 market data tables and 26 figures on "Immunodeficiency Therapeutics Market” - Global Forecast to 2028.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
